Article Text

Download PDFPDF
Letter to the Editor
The impact of statin therapy on survival for inhospital cardiac arrest
  1. Rami Khoury Abdulla1,2,
  2. Ed Kheder2,
  3. Raymond Yeow3,
  4. Shaiva Ginoya Meka2,
  5. Omar Yaldo3,
  6. Amr E Abbas1,3
  1. 1 Department of Cardiovascular Medicine, Beaumont Health System, Royal Oak, Michigan, USA
  2. 2 Department of Internal Medicine, Beaumont Health System, Royal Oak, Michigan, USA
  3. 3 Oakland University William Beaumont School of Medicine (OUWB), Rochester, Michigan, USA
  1. Correspondence to Dr Rami Khoury Abdulla, Department of Cardiovascular Medicine, Royal Oak, Michigan 48073, USA; Rami.Khouryabdulla{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


We read with great interest the paper published by Hung et al describing the favorable impact of preceding statin therapy on survival following out-of-hospital cardiac arrest (OHCA).1 Cardiac arrest remains a major cause of morbidity and mortality, despite improvement in resuscitation efforts. Statins have been shown to decrease the incidence of sudden cardiac death in ischemic heart disease.2–4 We performed a retrospective study to examine the impact of statin pretreatment on in-hospital cardiac arrest (IHCA) survival.


This is a retrospective study conducted under the auspices of the Human Investigation Committee of the Research Institute of William Beaumont Hospital. All patients who suffered an IHCA and underwent cardiopulmonary resuscitation (CPR) at Beaumont hospital from April 2012 to December 2013 were included in the study. Exclusion criteria were for CPR in the setting of trauma, postoperatively, during pregnancy and postpartum. Out-of-the hospital cardiac arrest, patients who underwent hospice or palliative care approach were also excluded and patients with …

View Full Text


  • Contributors The first draft was written by RKA. All authors critically reviewed and approved the final manuscript and we have no conflicts of interest to disclose.

  • Ethics approval Beaumont Health Institutional Review Board (IRB: 2014-030)

  • Provenance and peer review Not commissioned; externally peer reviewed.